MYCN recruits the nuclear exosome complex to RNA polymerase II to prevent transcription-replication conflicts.
Animals
Ataxia Telangiectasia Mutated Proteins
/ genetics
BRCA1 Protein
/ genetics
Cell Line, Tumor
Cell Nucleus
/ enzymology
Cell Proliferation
DNA Breaks, Double-Stranded
DNA Replication
Exoribonucleases
/ genetics
Exosomes
/ enzymology
Female
Gene Expression Regulation, Neoplastic
HEK293 Cells
Humans
Male
Mice
N-Myc Proto-Oncogene Protein
/ genetics
NIH 3T3 Cells
Neuroblastoma
/ enzymology
Promoter Regions, Genetic
RNA Caps
/ genetics
RNA Polymerase II
/ genetics
Transcription Termination, Genetic
Transcription, Genetic
ATM
ATR
DCP1A
MYC
MYCN
Neuroblastoma
RNA Exosome
TFIIS
transcription-replication conflict.
Journal
Molecular cell
ISSN: 1097-4164
Titre abrégé: Mol Cell
Pays: United States
ID NLM: 9802571
Informations de publication
Date de publication:
06 01 2022
06 01 2022
Historique:
received:
12
02
2021
revised:
17
08
2021
accepted:
02
11
2021
pubmed:
1
12
2021
medline:
15
2
2022
entrez:
30
11
2021
Statut:
ppublish
Résumé
The MYCN oncoprotein drives the development of numerous neuroendocrine and pediatric tumors. Here we show that MYCN interacts with the nuclear RNA exosome, a 3'-5' exoribonuclease complex, and recruits the exosome to its target genes. In the absence of the exosome, MYCN-directed elongation by RNA polymerase II (RNAPII) is slow and non-productive on a large group of cell-cycle-regulated genes. During the S phase of MYCN-driven tumor cells, the exosome is required to prevent the accumulation of stalled replication forks and of double-strand breaks close to the transcription start sites. Upon depletion of the exosome, activation of ATM causes recruitment of BRCA1, which stabilizes nuclear mRNA decapping complexes, leading to MYCN-dependent transcription termination. Disruption of mRNA decapping in turn activates ATR, indicating transcription-replication conflicts. We propose that exosome recruitment by MYCN maintains productive transcription elongation during S phase and prevents transcription-replication conflicts to maintain the rapid proliferation of neuroendocrine tumor cells.
Identifiants
pubmed: 34847357
pii: S1097-2765(21)00952-7
doi: 10.1016/j.molcel.2021.11.002
pii:
doi:
Substances chimiques
BRCA1 Protein
0
BRCA1 protein, human
0
MYCN protein, human
0
N-Myc Proto-Oncogene Protein
0
RNA Caps
0
ATM protein, human
EC 2.7.11.1
Ataxia Telangiectasia Mutated Proteins
EC 2.7.11.1
RNA Polymerase II
EC 2.7.7.-
Exoribonucleases
EC 3.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
159-176.e12Informations de copyright
Copyright © 2021. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Declaration of interests The authors declare no competing interests.